Pechmajou Louis, Marijon Eloi, Perrot David, Jouven Xavier, Karam Nicole
Inserm, PARCC, université de Paris, 75015 Paris, France; Service de cardiologie, hôpital européen Georges-Pompidou, 20 rue Leblanc, 75015 Paris, France.
Inserm, PARCC, université de Paris, 75015 Paris, France; Service de cardiologie, hôpital européen Georges-Pompidou, 20 rue Leblanc, 75015 Paris, France.
Ann Cardiol Angeiol (Paris). 2020 Dec;69(6):365-369. doi: 10.1016/j.ancard.2020.10.003. Epub 2020 Oct 8.
Since the appearance of the COVID-19 pandemic in 2020, the direct mortality related to COVID-19 infections has been monitored worldwide, with a daily count of the number of deaths due to COVID-19. Several measures have been undertaken in the societal and professional field, and the healthcare systems have been reorganized to limit the virus spread, and to cope with the surge of hospital admissions for COVID-19. Questions have been raised regarding the indirect effect of the pandemic, with uncertainties regarding the impact of delays in non-COVID diseases management, due to lockdown, postponement of non-urgent medical consultations and interventions, and decrease in screening. Sudden cardiac death could have been impacted by all those changes, and is generally a good surrogate of public health. In the current article, we review the impact of the COVID-19 pandemic on the epidemiology and outcome of sudden cardiac death.
自2020年新冠疫情出现以来，全球范围内一直在监测与新冠病毒感染相关的直接死亡率，每日统计因新冠病毒导致的死亡人数。社会和专业领域已采取多项措施，医疗系统也进行了重组，以限制病毒传播，并应对因新冠病毒感染而激增的住院人数。关于疫情的间接影响也引发了一些问题，由于封锁、非紧急医疗咨询和干预的推迟以及筛查减少，非新冠疾病管理延误的影响存在不确定性。心源性猝死可能受到了所有这些变化的影响，并且通常是公共卫生的一个良好指标。在本文中，我们回顾了新冠疫情对心源性猝死的流行病学和结局的影响。
